XTANT MEDICAL HOLDINGS, INC. Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2025-11-10: Disclosure Rule10b51Arr Adopted; Period 2025-07-01..2025-09-30; Value No.
- 2025-11-10: Disclosure Non Rule10b51Arr Adopted; Period 2025-07-01..2025-09-30; Value No.
- 2025-11-10: Disclosure Rule10b51Arr Terminated; Period 2025-07-01..2025-09-30; Value No.
- 2025-11-10: Disclosure Non Rule10b51Arr Terminated; Period 2025-07-01..2025-09-30; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2025-11-10 10-Q | Rule10b51Arr Adopted | 2025-07-01..2025-09-30 | No | |
| 2025-11-10 10-Q | Non Rule10b51Arr Adopted | 2025-07-01..2025-09-30 | No | |
| 2025-11-10 10-Q | Rule10b51Arr Terminated | 2025-07-01..2025-09-30 | No | |
| 2025-11-10 10-Q | Non Rule10b51Arr Terminated | 2025-07-01..2025-09-30 | No | |
| 2025-09-15 DEF 14A | Insider Trading Policies Proc Adopted | 2024-01-01..2024-12-31 | Yes | |
| 2025-09-15 DEF 14A | Award Timing MNPI Disclosure | 2024-01-01..2024-12-31 | During 2024, we did not grant any stock options or similar awards as part of our equity compensation program. Our 2024 equity compensation program for executives consisted of a mix of PSU and DSU awards. With respect to the timing equity awards, for 2024, we determined to make annual executive equit… | |
| 2025-09-15 DEF 14A | Award Timing MNPI Considered | 2024-01-01..2024-12-31 | No | |
| 2025-09-15 DEF 14A | Pay versus Performance Table | 2024-01-01..2024-12-31 | Year Summary Compensation Table Total for PEO (1) ($) Compensation Actually Paid to PEO (2)(3) ($) Average Summary Compensation Table Total for Non-PEO Named Executive Officers (4) ($) Average Compensation Actually Paid to Non-PEO Named Executive Officers (5)(6) ($) Value of Initial Fixed $100 Inves… | |
| 2025-09-15 DEF 14A | Adjustment To PEO Compensation Footnote | 2024-01-01..2024-12-31 | PEO Summary Compensation Table Total for 2024 $ 2,461,736 Deduct: Stock awards (a) 1,807,132 Deduct: Option awards (b) 0 Add: Year-end value of equity awards granted during the year that are outstanding and unvested (c) 321,918 Add: Change in fair value of equity awards granted in prior years that a… | |
| 2025-09-15 DEF 14A | PEO Total Compensation | Individual: Peo | 2024-01-01..2024-12-31 | $2.46M |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: StockAwards; Individual: Peo | 2024-01-01..2024-12-31 | $1.81M |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: OptionAwards; Individual: Peo | 2024-01-01..2024-12-31 | $0.00 |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvested; Individual: Peo | 2024-01-01..2024-12-31 | $321.92K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvested; Individual: Peo | 2024-01-01..2024-12-31 | -$178.97K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYear; Individual: Peo | 2024-01-01..2024-12-31 | -$646.31K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYear; Individual: Peo | 2024-01-01..2024-12-31 | $0.00 |
| 2025-09-15 DEF 14A | PEO Actually Paid Compensation | Individual: Peo | 2024-01-01..2024-12-31 | $151.24K |
| 2025-09-15 DEF 14A | PEO Total Compensation | Individual: Peo | 2023-01-01..2023-12-31 | $1.71M |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: StockAwards; Individual: Peo | 2023-01-01..2023-12-31 | $209.06K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: OptionAwards; Individual: Peo | 2023-01-01..2023-12-31 | $209.27K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvested; Individual: Peo | 2023-01-01..2023-12-31 | $381.46K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvested; Individual: Peo | 2023-01-01..2023-12-31 | $346.35K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYear; Individual: Peo | 2023-01-01..2023-12-31 | $346.21K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYear; Individual: Peo | 2023-01-01..2023-12-31 | $0.00 |
| 2025-09-15 DEF 14A | PEO Actually Paid Compensation | Individual: Peo | 2023-01-01..2023-12-31 | $2.37M |
| 2025-09-15 DEF 14A | PEO Total Compensation | Individual: Peo | 2022-01-01..2022-12-31 | $1.06M |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: StockAwards; Individual: Peo | 2022-01-01..2022-12-31 | $0.00 |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: OptionAwards; Individual: Peo | 2022-01-01..2022-12-31 | $0.00 |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: YearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvested; Individual: Peo | 2022-01-01..2022-12-31 | $0.00 |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvested; Individual: Peo | 2022-01-01..2022-12-31 | $118.20K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: ChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYear; Individual: Peo | 2022-01-01..2022-12-31 | $55.51K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: ValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYear; Individual: Peo | 2022-01-01..2022-12-31 | $0.00 |
| 2025-09-15 DEF 14A | PEO Actually Paid Compensation | Individual: Peo | 2022-01-01..2022-12-31 | $1.23M |
| 2025-09-15 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2024-01-01..2024-12-31 | Average Non-PEO Named Executive Officers Average Summary Compensation Table Total for 2024 $ 997,723 Deduct: Average stock awards (a) 440,672 Deduct: Average option awards (b) 0 Add: Average year-end value of equity awards granted during the year that are outstanding and unvested (c) 51,483 Add: Ave… | |
| 2025-09-15 DEF 14A | Non PEO NEO Avg Total Compensation | Individual: NonPeoNeo | 2024-01-01..2024-12-31 | $997.72K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageStockAwards; Individual: NonPeoNeo | 2024-01-01..2024-12-31 | $440.67K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageOptionAwards; Individual: NonPeoNeo | 2024-01-01..2024-12-31 | $0.00 |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvested; Individual: NonPeoNeo | 2024-01-01..2024-12-31 | $51.48K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvested; Individual: NonPeoNeo | 2024-01-01..2024-12-31 | -$164.12K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYear; Individual: NonPeoNeo | 2024-01-01..2024-12-31 | -$50.09K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageFairValueOfEquityAwardsGrantedInPriorYearsThatFailToMeetTheApplicableVestingConditionsDuringTheYear; Individual: NonPeoNeo | 2024-01-01..2024-12-31 | $414.51K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYear; Individual: NonPeoNeo | 2024-01-01..2024-12-31 | $0.00 |
| 2025-09-15 DEF 14A | Non PEO NEO Avg Compensation Actually Paid | Individual: NonPeoNeo | 2024-01-01..2024-12-31 | -$20.19K |
| 2025-09-15 DEF 14A | Non PEO NEO Avg Total Compensation | Individual: NonPeoNeo | 2023-01-01..2023-12-31 | $1.06M |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageStockAwards; Individual: NonPeoNeo | 2023-01-01..2023-12-31 | $174.87K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageOptionAwards; Individual: NonPeoNeo | 2023-01-01..2023-12-31 | $176.50K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvested; Individual: NonPeoNeo | 2023-01-01..2023-12-31 | $382.80K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvested; Individual: NonPeoNeo | 2023-01-01..2023-12-31 | $94.07K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYear; Individual: NonPeoNeo | 2023-01-01..2023-12-31 | $58.16K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYear; Individual: NonPeoNeo | 2023-01-01..2023-12-31 | $0.00 |
| 2025-09-15 DEF 14A | Non PEO NEO Avg Compensation Actually Paid | Individual: NonPeoNeo | 2023-01-01..2023-12-31 | $1.24M |
| 2025-09-15 DEF 14A | Non PEO NEO Avg Total Compensation | Individual: NonPeoNeo | 2022-01-01..2022-12-31 | $772.51K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageStockAwards; Individual: NonPeoNeo | 2022-01-01..2022-12-31 | $200.94K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageOptionAwards; Individual: NonPeoNeo | 2022-01-01..2022-12-31 | $30.01K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageYearEndValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvested; Individual: NonPeoNeo | 2022-01-01..2022-12-31 | $276.76K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvested; Individual: NonPeoNeo | 2022-01-01..2022-12-31 | $17.54K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageChangeInFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYear; Individual: NonPeoNeo | 2022-01-01..2022-12-31 | -$5.97K |
| 2025-09-15 DEF 14A | Adjustment To Compensation | AdjToComp: AverageValueOfDividendEquivalentsAccruedOnEquityAwardsDuringTheYear; Individual: NonPeoNeo | 2022-01-01..2022-12-31 | $0.00 |
| 2025-09-15 DEF 14A | Non PEO NEO Avg Compensation Actually Paid | Individual: NonPeoNeo | 2022-01-01..2022-12-31 | $829.88K |
| 2025-09-15 DEF 14A | Compensation Actually Paid Vs Total Shareholder Return | 2024-01-01..2024-12-31 | Compensation Actually Paid and TSR . As demonstrated by the following graph, the amount of compensation actually paid to our NEOs is aligned with our cumulative TSR over the three-year period presented in the Pay versus Performance table above. The alignment of compensation actually paid with our cu… | |
| 2025-09-15 DEF 14A | Compensation Actually Paid Vs Net Income | 2024-01-01..2024-12-31 | Compensation Actually Paid and Net Income (Loss) . As demonstrated by the following graph, the amount of compensation actually paid to our NEOs is somewhat aligned with our net income (loss) for each of the three years presented in the Pay versus Performance table. | |
| 2025-09-15 DEF 14A | Restatement Does Not Require Recovery | RestatementDate: 2023-10-01 | 2024-01-01..2024-12-31 | Effective as of October 1, 2023, we adopted a clawback policy to provide for a mandatory clawback of incentive compensation paid to current and former executives under certain circumstances in the event a financial metric used to determine the vesting or payment of incentive compensation to an execu… |
| 2025-08-12 10-Q | Rule10b51Arr Adopted | 2025-04-01..2025-06-30 | No | |
| 2025-08-12 10-Q | Non Rule10b51Arr Adopted | 2025-04-01..2025-06-30 | No | |
| 2025-08-12 10-Q | Rule10b51Arr Terminated | 2025-04-01..2025-06-30 | No | |
| 2025-08-12 10-Q | Non Rule10b51Arr Terminated | 2025-04-01..2025-06-30 | No | |
| 2025-05-12 10-Q | Rule10b51Arr Adopted | 2025-01-01..2025-03-31 | No | |
| 2025-05-12 10-Q | Non Rule10b51Arr Adopted | 2025-01-01..2025-03-31 | No | |
| 2025-05-12 10-Q | Rule10b51Arr Terminated | 2025-01-01..2025-03-31 | No | |
| 2025-05-12 10-Q | Non Rule10b51Arr Terminated | 2025-01-01..2025-03-31 | No | |
| 2025-03-06 10-K | Material Terms Of Trading Arrangement | 2024-10-01..2024-12-31 | Rule 10b5-1 Plan and Non-Rule 10b5-1 Trading Arrangement Adoptions, Terminations, and Modifications During the three months ended December 31, 2024, none of our directors or “officers” (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated a “Rule 10b5-1 trading arrangement” or “… | |
| 2025-03-06 10-K | Rule10b51Arr Adopted | 2024-10-01..2024-12-31 | No | |
| 2025-03-06 10-K | Non Rule10b51Arr Adopted | 2024-10-01..2024-12-31 | No | |
| 2025-03-06 10-K | Rule10b51Arr Terminated | 2024-10-01..2024-12-31 | No | |
| 2025-03-06 10-K | Non Rule10b51Arr Terminated | 2024-10-01..2024-12-31 | No | |
| 2025-03-06 10-K | Insider Trading Policies Proc Adopted | 2024-01-01..2024-12-31 | Yes | |
| 2025-03-06 10-K | Award Timing MNPI Disclosure | 2024-01-01..2024-12-31 | During 2024, we did not grant any stock options or similar awards as part of our equity compensation program. Our 2024 equity compensation program for executives consisted of a mix of PSU and DSU awards. With respect to the timing equity awards, it is our policy to make annual executive equity grant… |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |